What was TSH Biopharm Corp. Ltd.’s price range in the past 12 months?
TSH Biopharm Corp. Ltd. lowest stock price was TWD 48.60 and its highest was TWD 62.20 in the past 12 months.
What is TSH Biopharm Corp. Ltd.’s market cap?
TSH Biopharm Corp. Ltd.’s market cap is TWD 2.25B.
When is TSH Biopharm Corp. Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TSH Biopharm Corp. Ltd.’s earnings last quarter?
TSH Biopharm Corp. Ltd. released its earnings results on Oct 29, 2026. The company reported TWD 2.638 earnings per share for the quarter.
Is TSH Biopharm Corp. Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does TSH Biopharm Corp. Ltd. pay dividends?
TSH Biopharm Corp. Ltd. pays a ― dividend of TWD 2.61 which represents an annual dividend yield of 4.45%. See more information on TSH Biopharm Corp. Ltd. dividends here
What is TSH Biopharm Corp. Ltd.’s EPS estimate?
TSH Biopharm Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TSH Biopharm Corp. Ltd. have?
TSH Biopharm Corp. Ltd. has 38,398,140 shares outstanding.
What happened to TSH Biopharm Corp. Ltd.’s price movement after its last earnings report?
TSH Biopharm Corp. Ltd. reported an EPS of TWD 2.638 in its last earnings report. Following the earnings report the stock price went up 1.479%.
Which hedge fund is a major shareholder of TSH Biopharm Corp. Ltd.?
Currently, no hedge funds are holding shares in TW:8432
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
TSH Biopharm Corp. Ltd.
TSH Biopharm Corporation Limited, a subsidiary of TTY Biopharm Company Limited, specializes in the development and commercialization of pharmaceutical products. Established in 1999 with its headquarters in Taipei, Taiwan, the company's market reach extends across Taiwan and other Asian territories. Its product portfolio encompasses a variety of therapeutic solutions, including treatments for cardiovascular, central nervous system, and gastrointestinal conditions, among others.